ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Perspectives on the development of neutralizing antibodies against SARS-CoV-2

Mitchell, Ho
Antibody Therapeutics2020-4-30DOI: 10.1093/abt/tbaa009
7被引2阅读
引用收藏
分享

摘要

<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 gains entry to human cells through its spike (S) protein binding to angiotensin-converting enzyme 2 (ACE2). Therefore, the receptor binding domain (RBD) of the S protein is the primary target for neutralizing antibodies. Selection of broad-neutralizing antibodies against SARS-CoV-2 and SARS-CoV is attractive and might be useful for treating not only COVID-19 but also future SARS-related CoV infections. Broad-neutralizing antibodies, such as 47D11, S309, and VHH-72, have been reported to target a conserved region in the RBD of the S1 subunit. The S2 subunit required for viral membrane fusion might be another target. Due to their small size and high stability, single-domain antibodies might have the ability to be administered by an inhaler making them potentially attractive therapeutics for respiratory infections. A cocktail strategy combining two (or more) antibodies that recognize different parts of the viral surface that interact with human cells might be the most effective.</jats:p>

相关
加载中…
  • Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Ju, Bin; Zhang, Qi; Ge, Jiwan; Wang, Ruoke; Sun, Jing; Ge, Xiangyang; Yu, Jiazhen; Shan, Sisi; Zhou, Bing; Song, Shuo; Tang, Xian; Yu, Jinfang; Lan, Jun; Yuan, Jing; Wang, Haiyan; Zhao, Juanjuan; Zhang, Shuye; Wang, Youchun; Shi, Xuanling; Liu, Lei; Zhao, Jincun; Wang, Xinquan*; Zhang, Zheng*; Zhang, Linqi*Nature, 2020, 584(7819): 115-+.
  • Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
    Ge, Jiwan; Wang, Ruoke; Ju, Bin; Zhang, Qi; Sun, Jing; Chen, Peng; Zhang, Senyan; Tian, Yuling; Shan, Sisi; Cheng, Lin; Zhou, Bing; Song, Shuo; Zhao, Juanjuan; Wang, Haiyan; Shi, Xuanling; Ding, Qiang; Liu, Lei; Zhao, Jincun; Zhang, Zheng*; Wang, Xinquan*; Zhang, Linqi*Nature Communications, 2021, 12(1): 250.被引 79
  • Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain
    Wang, Yanqun*; Zhang, Zhaoyong; Yang, Minnan; Xiong, Xinyi; Yan, Qihong; Cao, Lei; Wei, Peilan; Zhang, Yuting; Zhang, Lu; Lv, Kexin; Chen, Jiantao; Liu, Xuesong; Zhao, Xiaochu; Xiao, Juxue; Zhang, Shengnan; Zhu, Airu; Gan, Mian; Zhang, Jingjun; Cai, Ruoxi; Zhuo, Jianfen; Zhang, Yanjun; Rao, Haiyue; Qu, Bin; Zhang, Yuanyuan; Chen, Lei; Dai, Jun; Cheng, Linling; Hu, Qingtao; Chen, Yaoqing; Lv, Huibin; So, Ray T. Y.; Peiris, Malik; Zhao, Jingxian; Liu, Xiaoqing*Cell Reports, 2024, 43(1): 113653.
查看全部 →

发表信息

论文状态
公开发表
期刊
Antibody Therapeutics
发表日期
2020-04-30
卷期
第 3 卷, 第 2 期
页码
109-114
DOI
10.1093/abt/tbaa009
资助标注
National Institutes of Health[ZIA BC010891];National Cancer Institute[Z01 BC010891]

作者

  • M

    Mitchell, Ho (第一作者)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417